Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.53 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.53 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.53 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.52 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.52 |
| ▸ | ALPI | P09923 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | XIAP | P98170 | 1/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | AGXT | P21549 | 1/20 | 0.49 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.47 |
| ▸ | MMP1 | P03956 | 1/20 | 0.46 |
| ▸ | FCER2 | P06734 | 1/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.45 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1062090 | 1.00 | CYP2A6 (0.53) | CYP2A6ASIC3LOXL2S1PR4S1PR5 | |
| SCHEMBL4626056 | 1.00 | CYP2A6 (0.53) | CYP2A6ASIC3LOXL2S1PR4S1PR5 | |
| Trifluoroacetic Acid SCHEMBL6161390 | 0.92 | S1PR4 (0.46) | CYP2A6ASIC3LOXL2S1PR4S1PR5 | |
| SCHEMBL16461209 | 0.85 | CYP2A6 (0.58) | CYP2A6ASIC3LOXL2S1PR4S1PR5 | |
| SCHEMBL5323216 | 0.85 | CYP2A6 (0.50) | CYP2A6ASIC3LOXL2S1PR4S1PR5 | |
| SCHEMBL2032875 | 0.82 | CYP2A6 (0.50) | CYP2A6ASIC3LOXL2S1PR4S1PR5 | |
| SCHEMBL2030629 | 0.82 | CYP2A6 (0.50) | CYP2A6ASIC3LOXL2S1PR4S1PR5 | |
| SCHEMBL7026459 | 0.81 | AGXT (0.49) | CYP2A6ASIC3LOXL2AGXTBCL2L1 | |
| SCHEMBL26987594 | 0.79 | NNMT (0.54) | CYP2A6ASIC3LOXL2S1PR4S1PR5 | |
| SCHEMBL27130058 | 0.79 | NNMT (0.54) | CYP2A6ASIC3LOXL2S1PR4S1PR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12496350-B2 | Cyclic peptidyl inhibitors of CAL-PDZ binding domain | OHIO STATE INNOVATION FOUNDATION (US) | 2025-12-16 | — | — | US | claimed |
| US-20250353814-A1 | NON-PEPTIDIC CELL-PENETRATING MOTIFS | OHIO STATE INNOVATION FOUNDATION (US) | 2025-11-20 | — | — | US | claimed |
| US-12404236-B2 | Non-peptidic cell-penetrating motifs | OHIO STATE INNOVATION FOUNDATION (US) | 2025-09-02 | — | — | US | claimed |
| US-12329799-B2 | Peptidyl inhibitors of calcineurin-NFAT interaction | OHIO STATE INNOVATION FOUNDATION (US) | 2025-06-17 | — | — | US | claimed |
| WO-2025054727-A1 | RADIOLABELED COMPOUNDS FOR IN VIVO IMAGING OF GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR) AND TREATMENT OF GRPR-RELATED DISORDERS | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2025-03-20 | — | — | WO | claimed |
| US-20240360174-A1 | CELL-PENETRATING PEPTIDE SEQUENCES | OHIO STATE INNOVATION FOUNDATION | 2024-10-31 | — | — | US | claimed |
| US-20240173423-A1 | CYCLIC PEPTIDYL INHIBITORS OF CAL-PDZ BINDING DOMAIN | OHIO STATE INNOVATION FOUNDATION | 2024-05-30 | — | — | US | claimed |
| US-20240101509-A1 | NON-PEPTIDIC CELL-PENETRATING MOTIFS | OHIO STATE INNOVATION FOUNDATION | 2024-03-28 | — | — | US | claimed |
| CN-117567639-A | Polypeptide conjugates for intracellular delivery of binding peptides | 俄亥俄州国家创新基金会 | 2024-02-20 | — | — | CN | claimed |
| US-20240033318-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | OHIO STATE INNOVATION FOUNDATION | 2024-02-01 | — | — | US | claimed |
| EP-0833839-A1 | PEPTIDYL HETEROCYCLES USEFUL IN THE TREATMENT OF THROMBIN RELATED DISORDERS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1998-04-08 | — | — | EP | claimed |
| EP-0804463-A1 | NEUROKININE (TACHYKININE) ANTAGONISTS | BOEHRINGER INGELHEIM KG (DE) | 1997-11-05 | — | — | EP | claimed |
| WO-1996040742-A1 | PEPTIDYL HETEROCYCLES USEFUL IN THE TREATMENT OF THROMBIN RELATEDDISORDERS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1996-12-19 | — | — | WO | claimed |
| WO-1996040741-A1 | PEPTIDYL HETEROCYCLES USEFUL IN THE TREATMENT OF THROMBIN RELATED DISORDERS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1996-12-19 | — | — | WO | claimed |
| WO-1996040748-A1 | PEPTIDYL HETEROCYCLES USEFUL IN THE TREATMENT OF THROMBIN RELATED DISORDERS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1996-12-19 | — | — | WO | claimed |
| US-5523308-A | SERINE PROTEASES INHIBITORS; ORAL ANTICOAGULANTS; CHEMICAL INTERMEDIATES; DIPEPTIDES | ORTHO PHARMACEUTICAL CORPORATION | 1996-06-04 | — | — | US | claimed |
| WO-1995030687-A1 | NEUROKININE (TACHYKININE) ANTAGONISTS | BOEHRINGER INGELHEIM KG (DE) | 1995-11-16 | — | — | WO | claimed |
| EP-0276014-B1 | Anticoagulant peptides | MERRELL DOW PHARMA (US) | 1994-08-31 | — | — | EP | claimed |
| EP-0610487-A1 | NEW AMINOACID DERIVATES, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | BOEHRINGER INGELHEIM KG (DE) | 1994-08-17 | — | — | EP | claimed |
| WO-1994005693-A1 | NEW AMINOACID DERIVATES, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | BOEHRINGER INGELHEIM KG (DE) | 1994-03-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12404236-B2 | Non-peptidic cell-penetrating motifs | TIMM50, TIMM10, PITRM1 | CYP2A6 4596/4885ASIC3 2671/4885LOXL2 2844/4885 |
| US-20240101509-A1 | NON-PEPTIDIC CELL-PENETRATING MOTIFS | TIMM50, TIMM10, PITRM1 | CYP2A6 4596/4885ASIC3 2671/4885LOXL2 2844/4885 |
| US-20250353814-A1 | NON-PEPTIDIC CELL-PENETRATING MOTIFS | TIMM50, TIMM10, PITRM1 | CYP2A6 4596/4885ASIC3 2671/4885LOXL2 2844/4885 |
| US-20240173423-A1 | CYCLIC PEPTIDYL INHIBITORS OF CAL-PDZ BINDING DOMAIN | CNBP, CALU, CLSPN | CYP2A6 3353/4885ASIC3 1284/4885LOXL2 4725/4885 |
| US-12329799-B2 | Peptidyl inhibitors of calcineurin-NFAT interaction | CHP1, NFATC1, PPP3R1 | CYP2A6 3581/4885ASIC3 725/4885LOXL2 4495/4885 |
| US-20240360174-A1 | CELL-PENETRATING PEPTIDE SEQUENCES | VIP, LNPEP, NGLY1 | CYP2A6 4679/4885ASIC3 2540/4885LOXL2 3333/4885 |
| US-12496350-B2 | Cyclic peptidyl inhibitors of CAL-PDZ binding domain | CNBP, CALU, CLSPN | CYP2A6 3353/4885ASIC3 1284/4885LOXL2 4725/4885 |
| US-20240033318-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | CHP1, NFATC1, PPP3R1 | CYP2A6 3581/4885ASIC3 725/4885LOXL2 4495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.